Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly
Radiology Advances · 2024
DOI: 10.1093/radadv/umae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology Advances, 2024. Verfasst von Yoon Seong Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Samsung Research Funding Center of Samsung Electronics, National Research Foundation of Korea, Korea government.
Abstract (Originalsprache)
Background
The robustness of conventional amyloid PET harmonization across tracers has been questioned.
Purpose
To evaluate deep learning-based harmonization of amyloid PET in predicting conversion from cognitively unimpaired (CU) to mild cognitive impairment (MCI) and MCI to Alzheimer’s disease (AD). Materials and Methods We developed an amyloid PET-based deep-learning model to classify participants with a clinical diagnosis of AD-dementia vs CU across different tracers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Japanese ADNI, and Australian Imaging, Biomarker, and Lifestyle cohorts (n = 1050). The model output [deep learning-based probability of Alzheimer’s disease-dementia (DL-ADprob)], with other prognostic factors, was evaluated for predicting cognitive decline in ADNI-MCI (n = 451) and Harvard Aging Brain Study (HABS)-CU (n = 271) participants using Cox regression and area under time-dependent receiver operating characteristics curve (tdAUC) at 4-year follow-up. Subgroup analyses were performed in the ADNI-MCI group for conversion from amyloid-positive to AD and from amyloid negative to positive. Intraclass correlation coefficient (ICC) of DL-ADprob between tracers was calculated in the Global Alzheimer’s Association Interactive Network dataset (n = 155).
Results
DL-ADprob was independently prognostic in both ADNI-MCI (P < .001) and HABS-CU (P = .048) sets. Adding DL-ADprob to other factors increased prognostic performances in both ADNI-MCI (tdAUC 0.758 [0.721-0.792] vs 0.782 [0.742-0.818], tdAUC difference 0.023 [0.007-0.038]) and HABS-CU (tdAUC 0.846 [0.755-0.925] vs 0.870 [0.773-0.943], tdAUC difference 0.022 [−0.004 to 0.053]). DL-ADprob was independently prognostic in amyloid-positive (P < .001) and amyloid-negative subgroups (P = .007). DL-ADprob showed incremental prognostic value in amyloid-positive (tdAUC 0.666 [0.623-0.713] vs 0.706 [0.657-0.755], tdAUC difference 0.039 [0.016-0.064]), but not in amyloid-negative (tdAUC 0.818 [0.757-0.882] vs 0.816 [0.751-0.880], tdAUC difference −0.002 [−0.031 to 0.029]) subgroup. The pairwise ICCs of DL-ADprob between Pittsburgh compound B and florbetapir, florbetaben, and flutemetamol, respectively, ranged from 0.913 to 0.935.
Conclusion
Deep learning-based harmonization of amyloid PET improves cognitive decline prediction in non-demented elderly, suggesting it could complement conventional amyloid PET measures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
- Clinical Imaging Research Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- Department of Diagnostic Imaging, National University Health System, Singapore 119074, Singapore.
- Medical Artificial Intelligence Lab, School of Electrical and Electronic Engineering, Yonsei University, Seoul 03722, Korea.
- National Neuroscience Institute, Duke NUS Medical School, Singapore 169857, Singapore.
ORCID-Profile: Yoon Seong Choi, Eng-King Tan
Förderung
- Samsung Research Funding Center of Samsung Electronics
- National Research Foundation of Korea
- Korea government
Zitieren
APA
Choi, Y. S., Ngam, P. I., Lee, J. R., Hwang, D., Tan, E. K., Harvard Aging Brain Study, Australian Imaging Biomarkers and Lifestyle Study of Aging, Japanese Alzheimer’s Disease Neuroimaging Initiative, & Alzheimer’s Disease Neuroimaging Initiative (2024). Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly. Radiology Advances. https://doi.org/10.1093/radadv/umae019
Vancouver
Choi YS, Ngam PI, Lee JR, Hwang D, Tan EK, Harvard Aging Brain Study, et al. Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly. Radiology Advances. 2024. doi:10.1093/radadv/umae019
BibTeX
@article{Choi2024,
author = {Choi, Yoon Seong and Ngam, Pei Ing and Lee, Jeong Ryong and Hwang, Dosik and Tan, Eng-King and Harvard Aging Brain Study, Harvard Aging Brain Study and Australian Imaging Biomarkers and Lifestyle Study of Aging, Australian Imaging Biomarkers and Lifestyle Study of Aging and Japanese Alzheimer’s Disease Neuroimaging Initiative, Japanese Alzheimer’s Disease Neuroimaging Initiative and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
title = {Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly},
journal = {Radiology Advances},
year = {2024},
doi = {10.1093/radadv/umae019}
}
EUVIMED